As of 2026-10-17, the Fair Value of VistaGen Therapeutics Inc (VTGN) is -6.19 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.20 USD, the upside of VistaGen Therapeutics Inc is -3,194.57%.
With the market price of 0.20 USD and our fair value calculation, VistaGen Therapeutics Inc (VTGN) is not a good investment. Investing in VTGN stocks now will result in a potential loss of 3,194.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | 5Y Avg | |
| Net income | -47.76 | -59.25 | -29.36 | -51.42 | -69.68 | -51.50 |
| YoY growth | -166.37% | -24.06% | 50.44% | -75.12% | -35.53% | -50.13% |
| Market Cap (mil) | 10.93 |
| P/E | |
| Forward P/E |
| EPS | -1.24 |
| Avg earnings growth rate | -50.13% |
| TTM earnings | -67.62 |